115 related articles for article (PubMed ID: 1592467)
1. Captopril prevents chronic hypertension produced by infusion of endothelin-1 in rats.
Mortensen LH; Fink GD
Hypertension; 1992 Jun; 19(6 Pt 2):676-80. PubMed ID: 1592467
[TBL] [Abstract][Full Text] [Related]
2. Chronic hypertension produced by infusion of endothelin in rats.
Mortensen LH; Pawloski CM; Kanagy NL; Fink GD
Hypertension; 1990 Jun; 15(6 Pt 2):729-33. PubMed ID: 2190924
[TBL] [Abstract][Full Text] [Related]
3. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
[TBL] [Abstract][Full Text] [Related]
4. Salt-dependency of endothelin-induced, chronic hypertension in conscious rats.
Mortensen LH; Fink GD
Hypertension; 1992 Jun; 19(6 Pt 1):549-54. PubMed ID: 1592449
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effect of captopril and enalapril in endothelin-infused rats.
Yasujima M; Abe K; Kanazawa M; Yoshida K; Kohzuki M; Takeuchi K; Tsunoda K; Kudo K; Hiwatari M; Sato T
Tohoku J Exp Med; 1991 Mar; 163(3):219-27. PubMed ID: 2063404
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
[TBL] [Abstract][Full Text] [Related]
7. Cardiorenal actions of endothelin, Part I: Effects of converting enzyme inhibition.
Cao LQ; Banks RO
Life Sci; 1990; 46(8):577-83. PubMed ID: 2407919
[TBL] [Abstract][Full Text] [Related]
8. Impaired baroreflex sensitivity and responses to angiotensin converting enzyme inhibitor in salt-induced hypertension and its prevention by dietary calcium supplement in Sprague-Dawley rats.
Ladipo CO; Egbe PE; Ibu JO
Afr J Med Med Sci; 2006 Mar; 35(1):29-36. PubMed ID: 17209324
[TBL] [Abstract][Full Text] [Related]
9. Effect of infused captopril on blood pressure and the renin-angiotensin-aldosterone system in normal dogs subjected to varying sodium balance.
Morton JJ; Tree M; Casals-Stenzel J
Am J Cardiol; 1982 Apr; 49(6):1395-400. PubMed ID: 7041583
[TBL] [Abstract][Full Text] [Related]
10. Chronic endothelin-induced pressor and renal actions in conscious dogs do not require altered ANG II formation.
Wilkins FC; Kassab S; Kato T; Mizelle HL; Opgenorth TJ; Granger JP
Am J Physiol; 1995 Feb; 268(2 Pt 2):R395-402. PubMed ID: 7864234
[TBL] [Abstract][Full Text] [Related]
11. Cross-desensitization between angiotensin II and endothelin-1 in the pithed rat.
Guillon JM; Etiemble E; Roubert P; Auguet M; Chabrier PE; Braquet P
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S366-9. PubMed ID: 1725382
[TBL] [Abstract][Full Text] [Related]
12. Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension.
Quaschning T; d'Uscio LV; Shaw S; Viswambharan H; Ruschitzka FT; Lüscher TF
Nephrol Dial Transplant; 2001 Jun; 16(6):1176-82. PubMed ID: 11390717
[TBL] [Abstract][Full Text] [Related]
13. Preservation of renal function by angiotensin during chronic adrenergic stimulation.
Lohmeier TE; Yang HM
Hypertension; 1991 Mar; 17(3):278-87. PubMed ID: 1999358
[TBL] [Abstract][Full Text] [Related]
14. The interaction between atrial natriuretic peptides and angiotensin II in controlling sodium and water excretion in the rat.
Chamienia AL; Johns EJ
Br J Pharmacol; 1991 Aug; 103(4):1893-8. PubMed ID: 1833019
[TBL] [Abstract][Full Text] [Related]
15. Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive.
Brands MW; Hildebrandt DA; Mizelle HL; Hall JE
Hypertension; 1992 Jan; 19(1 Suppl):I83-9. PubMed ID: 1730459
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibition does not prevent development of ACTH-induced hypertension in sheep.
Spence CD; Coghlan JP; Denton DA; Fei DT; Mills EH; Whitworth JA; Scoggins BA
Clin Exp Pharmacol Physiol; 1985; 12(2):181-5. PubMed ID: 2988839
[TBL] [Abstract][Full Text] [Related]
17. Role of the renin-angiotensin system in the development of thyroxine-induced hypertension.
García del Rio C; Moreno MR; Osuna A; de Dios Luna J; García-Estañ J; Vargas F
Eur J Endocrinol; 1997 Jun; 136(6):656-60. PubMed ID: 9225731
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of the blood pressure and renal hemodynamic effects of captopril.
Hall JE; Granger JP
Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591
[TBL] [Abstract][Full Text] [Related]
19. Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: Role of arterial baroreflexes and vasoreactivity.
Nasser SA; Sabra R; Elmallah AI; El-Din MM; Khedr MM; El-Mas MM
Life Sci; 2016 Oct; 163():1-10. PubMed ID: 27575704
[TBL] [Abstract][Full Text] [Related]
20. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
